Your browser doesn't support javascript.
loading
Structural Basis of Saccharin Derivative Inhibition of Carbonic Anhydrase IX.
Leitans, Janis; Kazaks, Andris; Bogans, Janis; Supuran, Claudiu T; Akopjana, Inara; Ivanova, Jekaterina; Zalubovskis, Raivis; Tars, Kaspars.
Afiliación
  • Leitans J; Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.
  • Kazaks A; Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.
  • Bogans J; Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.
  • Supuran CT; NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.
  • Akopjana I; Latvian Biomedical Research and Study Center, Ratsupites 1, 1067, Riga, Latvia.
  • Ivanova J; Latvian Institute of Organic Synthesis, Aizkraukles 21, 1006, Riga, Latvia.
  • Zalubovskis R; Latvian Institute of Organic Synthesis, Aizkraukles 21, 1006, Riga, Latvia.
  • Tars K; Institute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, P. Valdena iela 3, 1048, Riga, Latvia.
ChemMedChem ; 18(22): e202300454, 2023 11 16.
Article en En | MEDLINE | ID: mdl-37837260
ABSTRACT
This study explores the binding mechanisms of saccharin derivatives with human carbonic anhydrase IX (hCA IX), an antitumor drug target, with the aim of facilitating the design of potent and selective inhibitors. Through the use of crystallographic analysis, we investigate the structures of hCA IX-saccharin derivative complexes, unveiling their unique binding modes that exhibit both similarities to sulfonamides and distinct orientations of the ligand tail. Our comprehensive structural insights provide information regarding the crucial interactions between the ligands and the protein, shedding light on interactions that dictate inhibitor binding and selectivity. Through a comparative analysis of the binding modes observed in hCA II and hCA IX, isoform-specific interactions are identified, offering promising strategies for the development of isoform-selective inhibitors that specifically target tumor-associated hCA IX. The findings of this study significantly deepen our understanding of the binding mechanisms of hCA inhibitors, laying a solid foundation for the rational design of more effective inhibitors.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Anhidrasas Carbónicas / Neoplasias Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Letonia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Anhidrasas Carbónicas / Neoplasias Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Letonia